HALO
Halozyme Therapeutics Inc
Price:  
53.18 
USD
Volume:  
1,243,561.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Relative Valuation

53.7%
Upside

As of 2024-07-15, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 81.75 USD. This relative valuation is based on P/E multiples. With the latest stock price at 53.18 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 53.7%.

The range of the Relative Valuation is 78.66 - 87.74 USD.

Range Selected
Trailing P/E multiples 31.4x - 31.4x 31.4x
Forward P/E multiples 29.7x - 31.8x 30.8x
Fair Price 78.66 - 87.74 81.75
Upside 47.9% - 65.0% 53.7%
53.18 USD
Stock Price
81.75 USD
Fair Price

HALO Relative Valuation - Historical P/E Data

Date P/E
2024-07-15 20.84
2024-07-12 21.23
2024-07-11 21.09
2024-07-10 21.14
2024-07-09 21.11
2024-07-08 20.98
2024-07-05 20.58
2024-07-03 20.76
2024-07-02 20.48
2024-07-01 20.77
2024-06-28 20.90
2024-06-27 20.61
2024-06-26 20.76
2024-06-25 20.92
2024-06-24 20.78
2024-06-21 20.58
2024-06-20 20.30
2024-06-18 20.07
2024-06-17 19.82
2024-06-14 19.76
2024-06-13 19.81
2024-06-12 19.82
2024-06-11 19.93
2024-06-10 20.42
2024-06-07 20.30
2024-06-06 20.53
2024-06-05 18.22
2024-06-04 17.68
2024-06-03 17.98
2024-05-31 17.68
2024-05-30 17.31
2024-05-29 17.07
2024-05-28 17.20
2024-05-24 17.49
2024-05-23 17.53
2024-05-22 18.16
2024-05-21 18.18
2024-05-20 17.95
2024-05-17 17.85
2024-05-16 18.12
2024-05-15 18.29
2024-05-14 17.49
2024-05-13 17.41
2024-05-10 17.23
2024-05-09 17.50
2024-05-08 16.77
2024-05-07 16.45
2024-05-06 16.31
2024-05-03 15.93
2024-05-02 15.90